Screener
Viridian Therapeutics, Inc. VRDN Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $164.99M+40.6% | $176.35M+51.7% | $212.38M+113% | $169.65M-15.3% | $117.32M+9.0% | ||
| $816.54M+83.1% | $585.84M+12.6% | $662.27M+7.2% | $321.25M-41.9% | $446.03M-3.8% | ||
| $1.08B+86.8% | $784.74M+19.4% | $894.23M+21.1% | $571.91M-25.5% | $578.75M-0.5% | ||
| $2.77M+153% | $1.13M-2.8% | $1.23M-0.6% | $1.13M-12.8% | $1.09M-27.9% | ||
| $10M— | —— | $0— | —— | —— | ||
| $1.1B+88.4% | $789.02M+19.4% | $899.42M+21.1% | $577.14M-25.2% | $582.32M-0.6% | ||
| $8.65M+1.6% | $13.31M+243% | $8.68M+305% | $10.06M+58.8% | $8.52M+171% | ||
| $181K-37.2% | $274K-4.9% | $367K+27.4% | $372K+29.2% | $288K0.0% | ||
| $63.79M+21.3% | $51.81M+53.6% | $70.7M+47.7% | $50.7M+22.6% | $52.59M+43.0% | ||
| $113.64M+820% | $36.09M+74.5% | $34.24M— | $20.89M+1.8% | $12.35M-29.4% | ||
| $13.69M-79.6% | $12.5M-77.9% | $20.03M-71.7% | $74.17M+15.2% | $67.16M+19.2% | ||
| 200M0.0% | 200M0.0% | 200M+24,591% | 200M0.0% | 200M0.0% | ||
| -$1.57B-32.7% | -$1.44B-33.3% | -$1.34B-34.4% | -$1.22B-33.0% | -$1.18B-41.0% | ||
| $662.1M+28.5% | $636.01M+5.2% | $722.17M+7.5% | $502.97M-28.9% | $515.17M-2.7% | ||
| $1.1B+88.4% | $789.02M+19.4% | $899.42M+21.1% | $577.14M-25.2% | $582.32M-0.6% |
FAQ
- What are Viridian Therapeutics, Inc.'s total assets?
- Viridian Therapeutics, Inc. (VRDN) holds $1.1B in total assets, up 88.4% year over year.
- How much debt does Viridian Therapeutics, Inc. have?
- Viridian Therapeutics, Inc. carries $114.4M in total debt against $662.1M of shareholders' equity, a debt-to-equity ratio of 0.17.
- How much cash does Viridian Therapeutics, Inc. have?
- Viridian Therapeutics, Inc. holds $165.0M in cash and equivalents.
- Can Viridian Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 16.95 — current assets exceed current liabilities.
- Where does Viridian Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Viridian Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
